Results 171 to 180 of about 499,734 (317)

Self-harming behaviors among forensic psychiatric patients living with intellectual disability. [PDF]

BMC Psychiatry
Kaggwa MM, Abaatyo J, Davids A, Brenton L, Komar M, Bradford JMW, Chaimowitz GA, Olagunju AT.   +7 more
europepmc   +1 more source

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

Molecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker, Keren Zohar, Martin Böttcher, Thomas Wartmann, Henry Freudenstein, Maximilian Doelling, Mihailo Andric, Wenjie Shi, Or Kakhlon, Katrin Hippe, Beatrix Jahnke, Dimitrios Mougiakakos, Franziska Baenke, Daniel Stange, Roland S. Croner, Michal Linial, Ulf D. Kahlert   +16 more
wiley   +1 more source

Harm reduction measures and injecting inside prison versus mandatory drugs testing: results of a cross sectional anonymous questionnaire survey [PDF]

, 1997
A G Bird, Sheila M. Gore, Sharon Hutchinson, Steff Lewis, S. Cameron, S. M. Burns   +5 more
openalex   +1 more source

Characterizing epithelial‐mesenchymal transition‐linked heterogeneity in breast cancer circulating tumor cells at a single‐cell level

Molecular Oncology, EarlyView.
In over 50% of non‐metastatic breast cancer patients, circulating tumor cells (CTCs) along the whole epithelial‐mesenchymal transition spectrum are detected. Total CTC number and individual phenotypes relate to aggressive disease characteristics, including lymph node involvement and higher tumor proliferation. At the single‐cell level, mesenchymal CTCs
Justyna Topa, Julia Richert, Tomasz Stokowy, Alicja Staśczak, Mariusz Szajewski, Maciej Ciesielski, Petra M. Grešner, Bartłomiej Tomasik, Łukasz Arcimowicz, Agnieszka Stankiewicz, Grażyna Suchodolska, Elżbieta Senkus, Wiesław Kruszewski, Anna J. Żaczek, Aleksandra Markiewicz   +14 more
wiley   +1 more source

Advancing research on strategies to reduce drug use and overdose-related harms: a community informed approach to establishing common data elements. [PDF]

Harm Reduct J
Saavedra LM, Christopher MC, Illei D, Kral AH, Ray B, Zibbell JE, Wagner KD, Borquez A, Jordan A, Seal D, Cerdá M, Mackesy-Amiti ME, Wilson JD, Pho MT, Behrends CN, Hassan H, Tomko C, Oga E, Cance JD.   +18 more
europepmc   +1 more source

Ludwig Harms

, 1988
Reinhart Müller
openalex   +1 more source

Nicotine replacement: a new approach to reducing tobacco-related harm [PDF]

, 1998
Carlos A. Jiménez-Ruíz, Michael Kunze, K.O. Fagerström   +2 more
openalex   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

Understanding the role of street medicine in harm reduction: a case study of Street Medicine St. Louis. [PDF]

Harm Reduct J
Gzesh A, Truel JS, Adams DR, Zabotka L, Malone S, Nolan NS.   +5 more
europepmc   +1 more source

Suicide attempts v. deliberate self-harm [PDF]

, 1999
Laofe Ogundipe
openalex   +1 more source